Treatment methods and remedial measures after missing avatrombopag (Su Kexin)

Avatrombopag (Avatrombopag) is an oral thrombopoietin receptor agonist. It is mainly used to treat patients with chronic liver disease-related thrombocytopenia and aplastic anemia. It stimulates the proliferation and differentiation of bone marrow megakaryocytes to increase platelet production. During the medication process, patients may sometimes miss doses and need to know the correct remedial measures to ensure treatment effectiveness and medication safety.

If only one dose is missed, the patient should take corresponding measures according to the missed dose: If there is a long gap between the next dose, the missed dose can be taken as soon as possible, and then the next dose can be continued as originally planned; if it is close to the next dose, the missed dose should be skipped and avoid taking a double dose at one time to reduce the risk of blood clots or other adverse reactions.

After missing a dose, patients should pay close attention to platelet changes and their own symptoms. If you miss a dose when platelets are extremely low or during medication before surgery, it is recommended to contact your doctor or treatment team in time to evaluate whether the next dose needs to be adjusted or additional monitoring is needed to prevent insufficient platelet levels from increasing the risk of bleeding.

In terms of long-term management, in order to reduce missed doses, patients can take some measures, such as setting medication reminders, recording daily medication, or taking medication at a fixed time. At the same time, patients should maintain communication with their doctors to ensure that they can receive professional guidance in the event of missed doses, so as to ensure the stability and safety of the efficacy of avatrombopag.

Reference materials:https://www.drugs.com/